FDA.reportPublic FDA data

levacetylleucine 1 GM Granules for Oral Suspension

RxCUI
2693617
RxNorm name
levacetylleucine 1 GM Granules for Oral Suspension
Display name
levacetylleucine 1 GM Granules for Oral Suspension
Full name
levacetylleucine 1 GM Granules for Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0f248e55-d1bb-13f9-e063-6294a90a05celevacetylleucine 1 GM Granules for Oral Suspension [PSN] · levacetylleucine 1000 MG Granules for Oral Suspension [SCD] · levacetylleucine 1 GM Granules for Oral Suspension [SY]35These highlights do not include all the information needed to use AQNEURSA safely and effectively. See full prescribing information for AQNEURSA. AQNEURSA™ (levacetylleucine) for oral suspension Initial U.S. Approval: 202420250123